Quality of live of HIV / AIDS Patients for Loss to Follow Up Antiretroviral Therapy in Semarang, Indonesia

Abstract

Introduction: Loss to Follow up ( LTFU) Antiretroviral (ARV) therapy of HIV and AIDS will have an
impact on their quality of life indicated by a decrease in CD4 cell counts.
Objective: The purpose of the study was to explore the quality of HIV and AIDS patients who were Loss
to Follow up ARV therapy.
Methods: A retrospective cohort study design on 140 HIV/AIDS patients receiving ARV regimen therapy
was recorded in the PDP service in Semarang City in the period of January 2015 – Oktober 2019, aged 18-65
years old, the sample consisted of two groups of Loss to Follow Up and retention group. Statistical analysis
using survival analysis with cox regression 95% confidence interval.
Result: The result showed that the Loss to Follow Up patient with ARV therapy showed a risk to the quality
of life (HR, 1.85; 95% CI, 1.110-3.098), a decrease in the quality of life of patient group Loss to Follow Up
occurred at 48th months.
Conclusion: Loss to Follow Up ARV therapy will decreasethe quality of patients with HIV/AIDS (ODHA),
therefore it is necessary to improve counseling to commit the consistency in therapy.